Novel drug compositions and dosage forms of topiramate

Details for Australian Patent Application No. 2004268661 (hide)

International Classifications

Event Publications

16 November 2006 Section 223 Application Received

ALZA CORPORATION An application to extend the time from 02 Apr 2006 to 02 Aug 2006 in which to enter the National Phase has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2005

25 January 2007 Section 223 Application Allowed

ALZA CORPORATION The time in which to enter the National Phase has been extended to 02 Aug 2006. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

1 February 2007 PCT application entered the National Phase

PCT publication WO2005/020959 Priority application(s): WO2005/020959

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.